Artificial Intelligence Predicts Genetics of Cancerous Brain Tumors in Under 90 Seconds - Neuroscience News

Summary: New artificial intelligence technology is able to screen for genetic mutations in brain cancer tumors in less than 90 seconds. Using artificial intelligence, researchers have discovered how to screen for genetic mutations in cancerous brain tumors in under 90 seconds -- and possibly streamline the diagnosis and treatment of gliomas, a study suggests. A team of neurosurgeons and engineers at Michigan Medicine, in collaboration with investigators from New York University, University of California, San Francisco and others, developed an AI-based diagnostic screening system called DeepGlioma that uses rapid imaging to analyze tumor specimens taken during an operation and detect genetic mutations more rapidly. In a study of more than 150 patients with diffuse glioma, the most common and deadly primary brain tumor, the newly developed system identified mutations used by the World Health Organization to define molecular subgroups of the condition with an average accuracy over 90%. The results are published in Nature Medicine. "This AI-based tool has the potential to improve the access and speed of diagnosis and care of patients with deadly brain tumors," said lead author and creator of DeepGlioma Todd Hollon, M.D., a neurosurgeon at University of Michigan Health and assistant professor of neurosurgery at U-M Medical School.